Graziella Pellegrini is Full Professor at the University of Modena and Reggio Emilia and Cell Therapy Program Coordinator at the Centre for Regenerative Medicine “Stefano Ferrari”. She is also co-founder and R&D Director at Holostem Terapie Avanzate S.r.l.
She graduated in Chemistry and Pharmaceutical Technologies (1988) and in Pharmacy (1889) at the University of Genova. She coordinated scientific teams in laboratories in different cities.
Prof. Pellegrini is founding member of the International Ocular Surface Society and member of major scientific societies and international committees.
She was awarded for a research on central nervous system, for research on ocular pathology and for research on urethra and received the ISSCR Award of Innovation in 2018 (with Michele De Luca). Author of 9 patents, 9 book chapters and over 70 peer reviewed publications in the major international journals, she was invited speaker or chairman in approximately 230 major international meetings on Stem Cells and Regenerative Medicine.
Prof. Pellegrini is one of the two inventors of the technology for culture and transplantation of limbal stem cells for treatment of blindness due to corneal stem cell deficiency and collaborated to the orphan drug designation and European registration of the therapy. She developed other translational medicine protocols for treatment of third-degree burns, depigmentation and is collaborating to a phase I clinical trial on gene therapy of epidermolysis bullosa. She is currently working with her team, on oral mucosa, urethra and airway epithelium.